Bio Medica Laboratories Limited
ListedSMEHealthcare / Pharmaceuticals · NSE
Bio Medica Laboratories is a pharmaceutical company engaged in manufacturing parenteral formulations for both human and veterinary healthcare segments. The company produces a wide range of ethical drugs, generic medicines, and OTC products, primarily in liquid and dry powder injectable forms. Its portfolio includes 58 liquid injectables and 15 dry powder injectable products available in single-dose and multi-dose formats. Operating on a B2B contract manufacturing model, the company develops customized formulations according to client requirements. Supported by GMP and GLP certifications, Bio Medica runs two manufacturing facilities in Indore, Madhya Pradesh, focusing on quality production and pharmaceutical formulation development.
Price Band
₹132 – ₹139
Issue Size
₹377.20 L Cr
Lot Size
1000 shares
GMP
₹7
-5.0%
Est. Listing
₹132
at current GMP
Subscribed
2.31x
overall
Open
21 May 2026
Close
25 May 2026
Allotment
26 May 2026
Refund
27 May 2026
Demat Credit
28 May 2026
Listing
29 May 2026
Last updated 4 months ago
Live Grey Market Premium
Bio Medica Laboratories Limited GMP Today
Last updated: 29 May 2026
Current Premium
₹-7-5.0%
Issue Price (Upper)
₹139
Band: ₹132 – ₹139
Estimated Listing Price
₹132
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,39,000
Estimated Profit / Lot
₹0
1000 × ₹-7
Bio Medica Laboratories Limited GMP Historical Trend
GMP History
Grey Market Premium trend
-₹7
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 27 Sep 2026 | -₹7 | -5.0% | ₹132 |
| 26 Sep 2026 | -₹7 | -5.0% | ₹132 |
| 25 Sep 2026 | — | -4.5% | ₹133 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Bio Medica Laboratories Limited Public Issue & Market Profile
Bio Medica Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹37,72,000 Crores. The shares are offered at a price band of ₹132 to ₹139 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2026-05-25, the basis of allotment is scheduled to be finalized on 2026-05-26. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Skyline Financial Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Bio Medica Laboratories Limited IPO GMP today?
The latest grey market premium for Bio Medica Laboratories Limited IPO is ₹-7, which indicates an expected listing price of ₹132.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.